Page last updated: 2024-10-15
oxysophocarpine
Cross-References
ID Source | ID |
---|---|
PubMed CID | 129316889 |
MeSH ID | M0134080 |
Synonyms (2)
Synonym |
---|
oxysophocarpine |
26904-64-3 |
Research Excerpts
Overview
Oxysophocarpine (OSC) is a traditional Chinese medicine isolated from legumes. It exerts vital functions on many human diseases.
Pharmacokinetics
Excerpt | Reference |
---|---|
"To establish an HPLC-MS method for simultaneous determination of matrine, oxymatrine and oxysophocarpine in rat plasma after oral administration of herbal preparation, namely Sanwu Huangqin decoction, and the pharmacokinetic porameters were calculated as well." | ( [Simultaneous determination of matrine, oxysophocarpin and oxymatrine in rat plasma by HPLC-MS and its application in the pharmacokinetic study]. Bi, KS; Chen, XH; Lian, JW; Wang, ZW; Zhang, L; Zhou, H, 2008) |
Dosage Studied
Excerpt | Reference |
---|---|
"To establish a suitable dosage form for a traditional anti-anaphylaxis Chinese medicine of Kushen recipe, and investigate the effect of cutaneous permeation in vitro of the recipe." | ( [Studies on cutaneous permeation in vitro of Kushen recipe gel]. Hu, JH; Liu, JY; Peng, C; Qin, Z; Wang, J; Zhu, QG, 2007) |
"It was certified that the purifying extraction gel had improved the effect of cutaneous permeation of alkaloids, and it is the befitting dosage form for Kushen recipe to treat anaphylaxis disease in skin." | ( [Studies on cutaneous permeation in vitro of Kushen recipe gel]. Hu, JH; Liu, JY; Peng, C; Qin, Z; Wang, J; Zhu, QG, 2007) |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (29)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (3.45) | 18.7374 |
1990's | 2 (6.90) | 18.2507 |
2000's | 5 (17.24) | 29.6817 |
2010's | 18 (62.07) | 24.3611 |
2020's | 3 (10.34) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 29 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |